Dr. Kurt R. Gehlsen | The Research Gate

Dr. Kurt R. Gehlsen

Florida, USA

Vice President and Chief Scientific Officer Biorasi, Inc.

About Dr. Kurt R. Gehlsen

Dr. Gehlsen is the Vice President and Chief Scientific Officer (CSO) of Biorasi, Inc. and Head of the Medical and Scientific Affairs Group. Prior to Biorasi, Dr. Gehlsen was Vice President and CSO of Research Corporation Technologies (RCT), a early-stage investment and development firm in Tucson, AZ from 2005 to 2018. Dr. Gehlsen was Senior Vice President, Development and Chief Scientific Officer at Maxim Pharmaceuticals, a public San Diego biopharmaceutical company from 1996 to 2004 and developed CepleneTM as the first immune-oncology drug to be approved as a remission maintenance therapy for AML. Prior to Maxim, Dr. Gehlsen was founder and Chief Executive Officer of Trauma Products, a San Diego start-up company that developed and obtained approval of RescueFlowTM, a small volume resuscitation solution for life-threatening trauma with the US Army. He also was Director of Research and Head of Molecular and Cellular Biology, Experimental Medicine Division of Pharmacia, AB. Dr. Gehlsen was a Postdoctoral Fellow and Research Associate at the Burnham Institute and has held research positions as Associate Professor at the Sidney Kimmel Cancer Center in La Jolla, Associate Staff Scientist at the California Institute for Biological Research and as Founder, Vice President and Chief Operating Officer at the La Jolla Institute for Experimental Medicine.

Upcoming Conferences

CANCER SCIENCE & THERAPEUTICS 2020 “Webinar”
Cancer Science & Therapeutics 2020 "Webinar"
Theme: New Challenges in Cancer Treatment and Research During COVID-19 Pandemic
Virtual
October 3rd, 2020
Cancer Science & Therapeutics 2021
Cancer Science & Therapeutics 2021
Theme: Understanding Covid-19 & Cancer through Multidisciplinary Approach
Vancouver, Canada
April 15th - April 17th, 2021

MEET THE EXPERTS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Dr. Denise Korniewicz, Maryland, USA
Dr. Denise Korniewicz
Maryland. USA
Professor at Wilkes University:Passan School of Nursing
Dr. Deborah M Leveille, Alabama, USA
Deborah M Leveille,PhD,RN,CNL
Alabama,USA
Dean of Nursing at Fortis College-Montgomery, National Nursing Curriculum Committee Chair
Dr. Adele Webb, Ohio, USA
Adele Webb, PhD, RN, FNAP, FAAN
Ohio,USA
Executive Dean of Healthcare Initiatives at Capella University
Dr. Oliver J. Morgan, Pennsylvania , USA
Oliver J. Morgan, Ph.D., LMFT, MAC
Pennsylvania,USA
Professor Scranton, PA , Counseling & Human Services University of Scranton
Dr. Hank C. Hill, California, USA
Hank C. Hill, MD, Surgical Oncology
Florida, USA
Fellowship-Trained Surgical Oncologist Board Certified General Surgeon
Prof. Dr. Fusun Terzioglu, Ankara, Turkey
Prof.Dr. Fusun Terzioglu (RN, Msc, PhD) Atilim University
Ankara Province, Turkey
Dean of Faculty of Health Science, Ankara, Turkey
Dr. Subbaya Subramanian
Dr. Subbaya Subramanian
St. Paul, USA
Associate Professor Department of Surgery University of Minnesota
Hilal Arnouk, MD, PhD
Hilal Arnouk, MD, PhD
Chicago, USA
Assistant Professor at the Department of Pathology at Midwestern University
Michael Retsky, PhD
Michael Retsky, PHD
Connecticut, USA
Research Associate at Harvard T.H. Chan School of Public Health
Dr. Reezena H. Malaska, Florida, USA
Dr. Reezena H. Malaska, DNP, MSN, RN, CCRN
Florida, USA
Critical Care Educator/Clinical Instructor/Professor
Myron R. Szewczuk, Ph.D.
Myron R. Szewczuk, Ph.D.
Ontario, Canada
Professor of Immunology, Queen’s University, Kingston, Ontario K7L3N6 Canada
Dr. Kurt R. Gehlsen
Dr. Kurt R. Gehlsen
Florida, USA
Vice President and Chief Scientific Officer Biorasi, Inc.